daptomycin Vials, lyophilized injection 350 mg, 500 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
FDA, EU GMP
Comments
Storage conditions: Between 2-8°C (36-46°F) and Store below 25°C (77°F) (EU dossier (filing Q1, 2024) Shelf life 24 months)
Manufacturer #1187
This company specializes in providing critical care therapies and anti-infective treatments for serious and life-threatening infections. They manufacture both Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms (FDFs), offering a range of products from generics to specialty pharmaceuticals. Their key focus lies in anti-infective treatments, particularly in the areas of oncology and critical care. The company operates across various regions, including Europe, North America, and Asia, with strong manufacturing facilities in the US, China, Denmark, and Hungary. The company is a leading supplier of Vancomycin and Colistimethate Sodium (CMS) and has a track record of over a century in the pharmaceutical industry. They boast state-of-the-art manufacturing sites, robust research and development capabilities, and a commitment to sustainability.

Manufacturer usually replies in 4 days

What is the drug Daptomycin?

Daptomycin is a lipopeptide antibiotic. It is used to treat bacterial infection of the skin caused by gram-positive microorganisms, Staphylococcus aureus, and bloodstream infection. It is administered only by intravenous processes. Daptomycin is a natural compound found in the saprotroph soil. Daptomycin was the first lipopeptide antimicrobial medication to be marketed. Today, it represents 83 % of in vitro antibiotics for gram-positive infections. Dasatinib medication is generally used to replace Gleevec when it is no longer efficient on patients or when the patients suffer from too strong side effects.

Wholesalers and manufacturers of Daptomycin

Daptomycin suppliers marketed it in the form of powder or injection for solutions. The medication is available either by its generic name, Daptomycin, first launched by Teva or by its brand name Cucibin marketed by Cubist Pharmaceuticals. Daptomycin was approved to be marketed in 2003 in the United States and in 2006 in the European Union.
The medication can be manufactured by Pfizer, Merck, and many others thanks to partnerships with Cubist. Counting only in China, there are more than 230 Daptomycin suppliers.

Daptomycin for sale:

The retail prices for one dose of Daptomycin intravenous powder for injection for 350 mg can fluctuate from $60 to $240, and for one dose of 500 mg, it can cost from $85 to $175, in the US market.
On Pipelinepharma online B2B marketplace, Daptomycin is mostly available from Turkey, where the medication was discovered. The platform helps Daptomycin distributors to find globally qualified manufacturers through quality control procedures. On the company website, you can find a list of many pharmaceutical products, including Daptomycin. If you are interested in this product, you can easily place an order on the Pipelinepharma platform to find Daptomycin manufacturers.

How to use Daptomycin drugs?

Depending on the Daptomycin treatment you follow, the use of the medication will be different. Taking Daptomycin for a skin and structure infection, an adult should take 4 mg/kg in vitro every 24 hours for 7 to 14 days.
If it is to treat Bacteremia, an adult should take 6 mg/kg IV every 24 hours for 2 to 6 weeks.
Daptomycin medication can have some side effects, the most common ones are: swelling of some body parts such as the face, arms, hands, lower legs, or feet, a fever, a rapid and unusual gain or loss of weight.
It must be stored in the refrigerator. If Daptomycin is mixed with a diluent, it still must be stored in the refrigerator but It must be taken within the following 48 hours.